Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market 2018-2022 - Unmet Need for Existing Therapies is Hindering Market Growth - ResearchAndMarkets.com

DUBLIN--()--The "Global Post-Traumatic Stress Disorder (PTSD) Therapeutics Market 2018-2022" report has been added to ResearchAndMarkets.com's offering.

The global post-traumatic stress disorder (PTSD) therapeutics market is expected to grow at a CAGR of 1.26% during the period 2018-2022.

The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

According to the report, one of the major drivers for this market is increasing initiatives by public and private organizations. Several public and private organizations are taking initiatives to raise awareness about PTSD and improve access to its treatment. For instance, to bring greater awareness about PTSD, the US Senate has designated June 27th as the national PTSD awareness day.

Further, the report states that one of the major factors hindering the growth of this market is unmet need for existing therapies. The PTSD medications currently approved by the FDA for the treatment of PTSD (paroxetine and sertraline) do not improve the full range of its symptoms. They show little evidence of treatment effect in men and lack clinical evidence of efficacy in people whose traumatic event was combat-related and carry suicidality warnings. Furthermore, the approved SSRIs and SNRIs have been associated with mild to moderate side effects such as upset stomach, sweating, headache, dizziness, and sexual side effects such as decreased desire to have sex or difficulty in having an orgasm.

Key Vendors

  • GlaxoSmithKline
  • Pfizer
  • Eli Lilly and Company
  • H. Lundbeck

Key Topics Covered

1. Executive Summary

2. Scope of the Report

3. Research Methodology

4. Market Landscape

5. Pipeline Landscape

6. Market Sizing

7. Five Forces Analysis

8. Market Segmentation by Product

9. Customer Landscape

10. Regional Landscape

11. Decision Framework

12. Drivers and Challenges

13. Market Trends

14. Vendor Landscape

15. Vendor Analysis

For more information about this report visit https://www.researchandmarkets.com/research/6dxrw7/global?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Mental Disorders Drugs

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Mental Disorders Drugs